FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Articles|January 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of today, January 6, 2022, at 5:20 PM, EDT:
• 73.9% of total US population has received at least 1 dose
• 62.3% of total US population is fully vaccinated
• 62.3% of total US population is fully vaccinated
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Vermont: 77.8%
2. Puerto Rico: 77.3%
3. Rhode Island:76.9%
4. Maine: 76.1%
5. Connecticut: 75%
2. Puerto Rico: 77.3%
3. Rhode Island:76.9%
4. Maine: 76.1%
5. Connecticut: 75%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, January 6, 2022 at 5:21 PM, EDT, there have been:
• 58 292 112 confirmed cases and
• 833 492 deaths
• 833 492 deaths
The 5 states with the highest total confirmed cases are:
1. California: 5 856 997
2. Texas: 4 895 396
3. Florida: 4 419 665
4. New York: 3 884 843
5. Illinois: 2 339 534
2. Texas: 4 895 396
3. Florida: 4 419 665
4. New York: 3 884 843
5. Illinois: 2 339 534
Deaths: California has the highest number of deaths due to COVID-19 with 76 754 reported fatalities, followed by Texas with 76 259 and Florida with 62 542.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 299 547 351 confirmed cases, 5 470 839 deaths, and 9 334 450 393 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
EASD 2026: Oral semaglutide users lost 4.1% of body weight 3 months after switching from injections in an observational study without a comparator group.
Advertisement
Advertisement
Trending on Patient Care Online
1
Immunizing Against Pain and Fear: Rethinking the Vaccination Experience
2
9 Drugs Approved for Primary Care: Q3 2026
3
HIV Testing Before and During PrEP: Getting It Right
4
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
5